title: Photodynamic therapy for subfoveal and juxtafoveal choroidal neovascularization associated with punctate inner choroidopathy.
abstract: OBJECTIVE
  To evaluate the treatment of subfoveal and juxtafoveal choroidal neovascularization (CNV) using verteporfin photodynamic therapy (vPDT) in patients affected by punctate inner choroidopathy (PIC).
  
  
  METHODS
  A chart review of 8 patients with CNV associated with PIC treated with vPDT was done.
  
  
  RESULTS
  The 8 patients (8 eyes) included 4 men and 4 women with a mean age of 30.9 years. Six of them presented juxtafoveal CNVs, and two had subfoveal CNVs, at presentation. Mean follow-up time was 22.7 months. The VA improved in five eyes, and three eyes declined. One patient developed a new CNV a few days after vPDT, and one had multiple CNVs at presentation. Two of the 3 patients with longer follow-up period presented late recurrences.
  
  
  CONCLUSIONS
  vPDT is a beneficial resource in stabilizing and also improving VA in PIC patients affected with subfoveal and juxtafoveal CNV, although one third of the patients retain poor visual acuity.
authors: Instituto de Oftalmobiología Aplicada (IOBA), Universidad de Valladolid, Avda, Ramon y Cajal, 7, Valladolid, 47005, Spain.
authors: Rosa M
authors: RM
authors: Coco
authors: Clairton Feitosa
authors: CF
authors: de Souza
authors: M Rosa
authors: MR
authors: Sanabria
mesh_terms: D000328:Adult; D020256:Choroidal Neovascularization / Q000150:complications / Q000188:drug therapy*; D002833:Choroiditis / Q000150:complications* / Q000473:pathology; D005260:Female; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D005584:Fovea Centralis / Q000473:pathology*; D005654:Fundus Oculi; D006801:Humans; D008297:Male; D008875:Middle Aged; D010778:Photochemotherapy / Q000379:methods*; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D012189:Retrospective Studies; D016896:Treatment Outcome; D000077362:Verteporfin; D014792:Visual Acuity
chemical_list: D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin